Yeter Ekrem, Denktas Ali E
Division of Cardiology, University of Texas Health Science Center at Houston TX, USA.
Future Cardiol. 2009 Jul;5(4):403-11. doi: 10.2217/fca.09.22.
In patients with ST-segment elevation myocardial infarction (STEMI) the shorter the reperfusion time, the better the outcome is, regardless of the reperfusion method. Effective, early and rapid reperfusion is the most important goal in the treatment of patients with STEMI. In majority cases of STEMI, transport or transfer to a percutaneous coronary intervention (PCI)-capable center will occur, sometimes bypassing the closest hospital facilities that are not PCI centers. The timely optimal reperfusion strategy might be a prehospital initiated pharmacological reperfusion with subsequent PCI. Reduced-dose prehospital fibrinolysis allows safe transport of STEMI patients to PCI centers for urgent culprit artery PCI, and may be a superior approach compared with transporting patients to the closest non-PCI hospital for fibrinolytic therapy. In this review we will discuss the evidence regarding reperfusion strategies in STEMI patients.
在ST段抬高型心肌梗死(STEMI)患者中,无论采用何种再灌注方法,再灌注时间越短,预后越好。有效、早期和快速再灌注是STEMI患者治疗的最重要目标。在大多数STEMI病例中,患者会被转运至有能力进行经皮冠状动脉介入治疗(PCI)的中心,有时会绕过距离最近但并非PCI中心的医院设施。及时的最佳再灌注策略可能是院前启动药物再灌注,随后进行PCI。降低剂量的院前溶栓可使STEMI患者安全转运至PCI中心进行紧急罪犯血管PCI,与将患者转运至距离最近的非PCI医院进行溶栓治疗相比,这可能是一种更优的方法。在本综述中,我们将讨论有关STEMI患者再灌注策略的证据。